Viewing Study NCT03085056


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-01-03 @ 2:01 PM
Study NCT ID: NCT03085056
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-03
First Post: 2017-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module